Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 26


Cost Effectiveness of Screening Colonoscopy Depends on Adequate Bowel Preparation Rates - A Modeling Study.

Kingsley J, Karanth S, Revere FL, Agrawal D.

PLoS One. 2016 Dec 9;11(12):e0167452. doi: 10.1371/journal.pone.0167452. eCollection 2016.


Trends in colorectal cancer admissions and stage at presentation: impact of screening.

Moghadamyeghaneh Z, Alizadeh RF, Phelan M, Carmichael JC, Mills S, Pigazzi A, Zell JA, Stamos MJ.

Surg Endosc. 2016 Aug;30(8):3604-10. doi: 10.1007/s00464-015-4662-3. Epub 2015 Nov 5.


A framework for evaluating the cost-effectiveness of patient decision aids: A case study using colorectal cancer screening.

Cantor SB, Rajan T, Linder SK, Volk RJ.

Prev Med. 2015 Aug;77:168-73. doi: 10.1016/j.ypmed.2015.05.003. Epub 2015 May 12.


Review of economic evidence in the prevention and early detection of colorectal cancer.

Jeong KE, Cairns JA.

Health Econ Rev. 2013 Sep 12;3(1):20. doi: 10.1186/2191-1991-3-20.


Screening methods for early detection of colorectal cancers and polyps: summary of evidence-based analyses.

Health Quality Ontario.

Ont Health Technol Assess Ser. 2009;9(6):1-65. Epub 2009 Sep 1. No abstract available.


Factors influencing colorectal cancer screening participation.

Gimeno GarcĂ­a AZ.

Gastroenterol Res Pract. 2012;2012:483417. doi: 10.1155/2012/483417. Epub 2011 Dec 1.


A systematic comparison of microsimulation models of colorectal cancer: the role of assumptions about adenoma progression.

Kuntz KM, Lansdorp-Vogelaar I, Rutter CM, Knudsen AB, van Ballegooijen M, Savarino JE, Feuer EJ, Zauber AG.

Med Decis Making. 2011 Jul-Aug;31(4):530-9. doi: 10.1177/0272989X11408730. Epub 2011 Jun 14.


Cost-effectiveness of colorectal cancer screening.

Lansdorp-Vogelaar I, Knudsen AB, Brenner H.

Epidemiol Rev. 2011;33:88-100. doi: 10.1093/epirev/mxr004. Epub 2011 Jun 1. Review.


Cost-effectiveness of colonoscopy.

Zauber AG.

Gastrointest Endosc Clin N Am. 2010 Oct;20(4):751-70. doi: 10.1016/j.giec.2010.07.008. Review.


Cost-effectiveness of colorectal cancer screening in high-risk Spanish patients: use of a validated model to inform public policy.

Ladabaum U, Ferrandez A, Lanas A.

Cancer Epidemiol Biomarkers Prev. 2010 Nov;19(11):2765-76. doi: 10.1158/1055-9965.EPI-10-0530. Epub 2010 Sep 1.


Prevention, screening and treatment of colorectal cancer: a global and regional generalized cost effectiveness analysis.

Ginsberg GM, Lim SS, Lauer JA, Johns BP, Sepulveda CR.

Cost Eff Resour Alloc. 2010 Mar 17;8:2. doi: 10.1186/1478-7547-8-2.


Calibration methods used in cancer simulation models and suggested reporting guidelines.

Stout NK, Knudsen AB, Kong CY, McMahon PM, Gazelle GS.

Pharmacoeconomics. 2009;27(7):533-45. doi: 10.2165/11314830-000000000-00000. Review.


What is the most cost-effective strategy to screen for second primary colorectal cancers in male cancer survivors in Korea?

Park SM, Kim SY, Earle CC, Jeong SY, Yun YH.

World J Gastroenterol. 2009 Jul 7;15(25):3153-60.


Individualizing colonoscopy screening by sex and race.

Lansdorp-Vogelaar I, van Ballegooijen M, Zauber AG, Boer R, Wilschut J, Winawer SJ, Habbema JD.

Gastrointest Endosc. 2009 Jul;70(1):96-108, 108.e1-24. doi: 10.1016/j.gie.2008.08.040. Epub 2009 May 24.


Can calcium chemoprevention of adenoma recurrence substitute or serve as an adjunct for colonoscopic surveillance?

Shaukat A, Parekh M, Lipscomb J, Ladabaum U.

Int J Technol Assess Health Care. 2009 Apr;25(2):222-31. doi: 10.1017/S026646230909028X. Epub 2009 Mar 31.


A cost-effectiveness analysis of folic acid fortification policy in the United States.

Bentley TG, Weinstein MC, Willett WC, Kuntz KM.

Public Health Nutr. 2009 Apr;12(4):455-67. doi: 10.1017/S1368980008002565. Epub 2008 Jul 1.


Cancer screening in renal transplant recipients: what is the evidence?

Wong G, Chapman JR, Craig JC.

Clin J Am Soc Nephrol. 2008 Mar;3 Suppl 2:S87-S100. doi: 10.2215/CJN.03320807. Review.


As tests evolve and costs of cancer care rise: reappraising stool-based screening for colorectal neoplasia.

Parekh M, Fendrick AM, Ladabaum U.

Aliment Pharmacol Ther. 2008 Apr;27(8):697-712. doi: 10.1111/j.1365-2036.2008.03632.x. Epub 2008 Jan 29.


A framework for tailoring clinical guidelines to comorbidity at the point of care.

Braithwaite RS, Concato J, Chang CC, Roberts MS, Justice AC.

Arch Intern Med. 2007 Nov 26;167(21):2361-5.


Referring patients to nurses: outcomes and evaluation of a nurse flexible sigmoidoscopy training program for colorectal cancer screening.

Dobrow MJ, Cooper MA, Gayman K, Pennington J, Matthews J, Rabeneck L.

Can J Gastroenterol. 2007 May;21(5):301-8. Review.

Supplemental Content

Support Center